prodigiosin and Colonic-Neoplasms

prodigiosin has been researched along with Colonic-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for prodigiosin and Colonic-Neoplasms

ArticleYear
Non-apoptotic concentrations of prodigiosin (H+/Cl- symporter) inhibit the acidification of lysosomes and induce cell cycle blockage in colon cancer cells.
    Life sciences, 2005, Nov-26, Volume: 78, Issue:2

    Prodigiosin (PG) is a bacterial red pigment with interesting immunosuppressive and apoptotic properties that have been partly attributed to its ability to uncouple V-ATPase through the promotion of the H+/Cl- symporter. In the present study, we investigate the effect of non-apoptotic concentrations of PG on the lysosomal-pH and on cell cycle progression in colon cancer cells. Lysosomal-pH was tested in DLD-1 cells using acridine orange vital staining. Orange granules, indicative of acidified lysosomes, decreased significantly in cells treated with 25 nM of PG for 1/2 h, and disappeared completely at 100 nM. This suggests that PG can induce lysosomal alkalinization without any apparent cytotoxic effect. Cell cycle progression was analysed in HT29 cells and we found that PG induces a blockage in the G1 phase. This blockage correlates with p21(WAF1/CIP1) induction, and it can be triggered either dependently or independently of p53. In conclusion, the reversible increase in lysosomal-pH and cytosol acidification induced by non-apoptotic concentrations of PG in colon cancer cells, suggests that the apoptotic process induced by PG can not be solely explained by changes in intracellular pH. The effect of intracellular acidification on cell cycle arrest must be analysed more exactly.

    Topics: Adenocarcinoma; Antineoplastic Agents; Antiporters; Blotting, Western; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; G1 Phase; Genes, p53; Humans; Hydrogen-Ion Concentration; Lysosomes; Microscopy, Fluorescence; Prodigiosin

2005
Prodigiosin-induced apoptosis in human colon cancer cells.
    Life sciences, 2001, Mar-16, Volume: 68, Issue:17

    Prodigiosin is a red pigment produced by various bacteria including Serratia marcescens. Colorectal cancer is one of the most frequent malignancies and one of the most frequent causes of cancer death in the Western world. Its treatment is far from satisfactory and the challenge to oncologists is to find novel chemical entities with less toxicity and greater effectiveness than those used in current chemotherapy. Here we characterize the apoptotic action of prodigiosin in colon cancer cells. DLD-1 and SW-620 human colon adenocarcinoma cells, NRK and Swiss-3T3 nonmalignant cells were assayed by the MTT assay, fragmentation pattern of DNA, Hoechst 33342 staining and study of PARP cleavage by Western blot, in order to characterize the prodigiosin-induced apoptosis. Prodigiosin was purified and its structure was confirmed. Metastatic SW-620 cells were more sensitive to prodigiosin (IC50: 275 nM) than DLD-1. We did not observe a significant decrease in the viability of NRK cells. We confirmed that prodigiosin induces apoptosis in both cancer cell lines by the characteristic DNA laddering pattern and condensed nuclei or apoptotic bodies identified by fluorescence microscopy. These results indicate that prodigiosin induces apoptosis in colon cancer cells.

    Topics: 3T3 Cells; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzimidazoles; Caspases; Cell Survival; Colonic Neoplasms; DNA; Drug Screening Assays, Antitumor; Enzyme Activation; Fluorescent Dyes; Humans; Mice; Prodigiosin; Serratia marcescens; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

2001